2
项与 CD19-TriCAR SILK cell therapy (Timmune Biotech) 相关的临床试验Adoptive Immunotherapy for Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell
This is a single arm, open-label, early phase Ⅰ study, to determine the safety and efficacy of CD19-TriCAR-T and CD19-TriCAR-SILK cell therapy in Children CD19+ Leukemia Non-Hodgkin lymphoma treatment.
Adoptive Immunotherapy for Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell
This is a single arm, open-label, early phase Ⅰ study, to determine the safety and efficacy of CD19-TriCAR-T and CD19-TriCAR-SILK cell therapy in Non-Hodgkin lymphoma treatment.
100 项与 CD19-TriCAR SILK cell therapy (Timmune Biotech) 相关的临床结果
100 项与 CD19-TriCAR SILK cell therapy (Timmune Biotech) 相关的转化医学
100 项与 CD19-TriCAR SILK cell therapy (Timmune Biotech) 相关的专利(医药)
100 项与 CD19-TriCAR SILK cell therapy (Timmune Biotech) 相关的药物交易